# A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

> **NCT06174987** · PHASE3 · RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 50 (estimated)

## Conditions studied

- Advanced Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** T-DXd

## Key facts

- **NCT ID:** NCT06174987
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-05
- **Primary completion:** 2026-08-03
- **Final completion:** 2028-01-17
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06174987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06174987, "A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06174987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*